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Editorial
I would like to announce the fi rst issue of “Nuclear Medicine 
Review” in 2018. The fi rst chapter consists of eight original articles. 
It opens with a paper written by Indian colleagues who concluded 
that the period of 3 months is good enough to accurately assess the 
success of primary angioplasty by myocardial quantitative perfusion 
SPECT imaging using Tc-99m — Tetrofosmin. 
The second one preparedby Iranian scientists shows that Vit. 
E signifi cantly attenuates the methotrexate-induced hepatotoxic-
ity, and 99mTc-phytate uptake in the liver as well as a liver image 
to be acceptable techniques for assessment of liver and spleen 
dama ges and/or their tissues protective effects in the animal model.
The next paper from Poland indicates that radioisotopic index of 
bone metabolism (IBM) is more sensitive than other methods of the 
assessment of changes occurring in a bone system under the infl u-
ence of testosterone therapy. Testosterone Defi ciency Syndrome, 
testosterone level, and IBM could be used as prognostic and thera-
peutic factors of osteoporosis and bone fractures in elderly men. 
The third article — from Thailand — compares the diagnostic 
accuracy of various parathyroid scintigraphy protocols for preopera-
tive localization of hyperfunctioning parathyroid glands. 
We received a paper from Germany concluding a good ef-
fi cacy and safety of radiosynoviorthesis using erbium-169 citrate 
in patients with arthritis of acromioclavicular joint in whom pre-
vious lines of treatment were insuffi cient. 
The next one is from Iran. The authors used mesoporous hy-
droxyapatite (HA) nanoparticles as a drug carrier and developed 
radiolabeled mesoporous HA containing 2-deoxy-D-glucose 
(2DG) and Doxorubicin (DOX) with technetium-99m (99mTc) 
which seems to be an attractive candidate in cancer and treat-
ment managing. 
The second article from Poland presents calibration factor 
fl uctuations for radiological protection instruments used in Nu-
clear Medicine Departments. It shows that the calibration factor 
for one particular instrument may fl uctuate by 50% in a one year 
period as well as by more than 100% for two instruments of the 
same type. 
The next Polish paper concerns the radioisotopic measure-
ments of GFR. The accepted criteria resulted in the extension of 
time intervals suitable for blood sampling are between 60 and 
90 minutes after injection for the fi rst sample and between 150 and 
180 minutes for the second sample. Uncertainty of results was as-
sessed as between 4 ml/min for GFR = 5–10 ml/min and 8 ml/min 
for GFR = 180 ml/min. They are acceptable and for high GFR 
values even comparable with the uncertainty of multi-sample 
measurements.
Clinical Vignette shows three interesting cases sent by our 
colleagues from Croatia, Iran and India.
In our new year magazine there are three reviews concern-
ing the role of 99mTc-DTPA retrobulbar SPECT in staging and 
follow-up of Graves’ orbitopathy (from Hungary), the use of 67Ga 
scintigraphy in patients with sarcoidosis by Polish authors and the 
signifi cance of splenic uptake on somatostatin receptor Imaging 
Studies from Kuwait. 
In the end of my letter from my heart. What is a memory if 
not remembering? What is the memory of a scientist, mentor and 
a doctor if not remembering of his papers, students and cured 
patients. On the 25th of November 2017, we lost Professor Julian 
Liniecki. Besides of many important scientifi c and clinical activities, 
he was the fi rst twelve-year Editor-in-Chief of our Nuclear Medicine 
Review Central and Eastern Europe. Professor Jacek Kuśmierek 
— his trainee and associate — has written a touching “In Memo-
riam: Professor Julian Liniecki”.  
Yours faithfully,
Grzegorz Kamiński
Editor-in-Chief 
Nuclear Medicine Review
 Dear Sirs and Madams,
